Search Type: drug or dietary supplement name
Search Term: rosiglitazone (AVANDIA)

Worst Pills, Best Pills Newsletter Articles | Additional Information from Public Citizen | Health Letter Articles

Worst Pills, Best Pills Newsletter Articles

Search results below include Worst Pills, Best Pills Newsletter Articles where your selected drug is a secondary subject of discussion
  • Type 2 Diabetes: A Guide to Prevention and Treatment [hide all summaries]
    (May 2014)
    The treatment options for Type 2 diabetes can be overwhelming. This article provides a comprehensive summary of our independent expert views on the best approaches for preventing and treating this common disease.
  • Escalating Criminal and Civil Violations: Pharma Has Corporate Integrity? Not Really [hide all summaries]
    (March 2014)
    Dr. Sidney Wolfe, founding editor of Worst Pills, Best Pills News, concludes that “there is pathological lack of corporate integrity in many drug companies.” Read this article to find out why.
  • When EMA and FDA Decisions Conflict: Differences in Patients or in Regulation? [hide all summaries]
    (December 2013)
    Are Americans more resistant to the risks and more likely to benefit from certain drugs than Europeans? Or is the European Medicines Agency (EMA) more resistant than the U.S. Food and Drug Administration (FDA) to the drug industry’s desire to get approval for drugs with unique risks but without compensating benefits? This article discusses two recently FDA-approved diet drugs deemed too unsafe for Europeans.
  • Diabetes Drugs Linked to Pancreas Disease [hide all summaries]
    (August 2013)
    Six recently approved diabetes drugs have been linked to an increased risk of pancreatitis and possibly pancreatic cancer.
  • Off Diabetes Pills! [hide all summaries]
    (July 2013)
    A recently published article mirrors our now-35-year-old publication “Off Diabetes Pills” in suggesting alternatives to pharmaceutical treatment for a large proportion of adult-onset diabetics.
  • Accentuate the Positive, Eliminate the Negative [hide all summaries]
    (May 2013)
    A study documents how little information about important drug risks is disclosed by the drug salespeople who visit so many doctors. Their strategy for increasing sales: Accentuate the positive and almost entirely eliminate the negative about these medicines.
  • Settlements for Prosecution of Fraud by Big Pharma at Record High [hide all summaries]
    (November 2012)
    Find out the latest about the pharmaceutical industry continuing to remain the number one defrauder of the Federal government. Why does this continue and what are an increasing number of states doing about it?
  • A Review of the ‘Gliptin’ Diabetes Drugs [hide all summaries]
    (March 2012)
    Find out why you should not use any of the three recently-approved diabetes drugs known as "gliptins".
  • Bladder Cancer Warning for Pioglitazone (ACTOS) [hide all summaries]
    (November 2011)
    Find out the full list of serious problems with pioglitazone (ACTOS) that cause it to be a DO NOT USE drug, of which bladder cancer is but the latest.
  • Drug Mix-Ups [hide all summaries]
    (June 2011)
    This article lists 355 drugs with names that are often confused with similar-sounding drug names. Find out what you can do to prevent getting the wrong drug.
  • Dangers of Mixing Alcohol with Certain Medications or Diseases [hide all summaries]
    (August 2008)
    The article discusses 273 drugs that can have harmful interactions with alcohol. Also reviewed are several ways in which these harmful interactions can occur: 1/ Medications Can Increase Alcohol Blood Levels 2/ Additive effects of medications and alcohol. One of the best- known drug-alcohol interactions is when alcohol, a depressant, is taken with other sedative medications, and excessive sedation or depression of respiration can occur 3/Alcohol can increase the blood levels of some medications leading to toxicity of these drugs. 4/ Alcohol also can reduce blood levels of some medications causing them to be less effective. Although some of the interactions between alcohol and medications mainly occur in people who drink heavily (three or more drinks on one occasion), many of these interactions may occur with much lower amounts of alcohol use, such as one to two drinks on an occasion. We strongly urge you to tell your physicians and other health care providers how much alcohol you are drinking so they can effectively assess the risks and advise you about the safe use of alcohol and medications.
  • Sitagliptin (JANUVIA) for Type-2 Diabetes [hide all summaries]
    (June 2007)
    Worst Pills, Best Pills reviews side effects and long-term effects of type-2 diabetes drug sitagliptin (JANUVIA) in this article.
  • Prescription Drug Ads and High Drug Prices: A Relationship? [hide all summaries]
    (April 2004)
    According to a supplement put out by Advertising Age in March entitled Fact Pack 2004 Edition, with additional information taken from Ad Age’s web site, the pharmaceutical industry continues to be quite adept at maintaining its place among the leading advertisers. Four of the top 25 U.S. advertisers, in terms of spending in this country during 2002, were drug companies. The article urges that you do not waste your time looking at or listening to prescription (or over-the-counter) drug ads.

Additional Information from Public Citizen

Search results below include Additional Information from Public Citizen where your selected drug is a secondary subject of discussion

Health Letter Articles

Search results below include Health Letter Articles where your selected drug is a secondary subject of discussion
  • What Happened in U.S. Health Care in 2007? [hide all summaries]
    (December 2007)
    This article summarizes 14 important health events that occurred in 2007, including seven that involve the pharmaceutical industry or its increasingly close financial partner, the FDA. Seven other reviews involve our so-called health care system.

SHOW primary search results for rosiglitazone (AVANDIA)

Copyright © 2018 Public Citizen's Health Research Group. All rights reserved.